Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

1. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.AJR. American journal of roentgenology · 2023
   Pooled it
2. Lesions hyper- to isointense to surrounding liver in the hepatobiliary phase of gadoxetic acid-enhanced MRI.European radiology · 2024
   Article
3. Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course.The British journal of radiology · 2024
   Review
4. β-Catenin-activated inflammatory hepatocellular adenoma with pigmentation and atypical features: a case report.Clinical journal of gastroenterology · 2023
   Article
5. Diagnostic Values of the Liver Imaging Reporting and Data System in the Detection and Characterization of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.Cureus · 2023
   Review
6. Hepatobiliary phases in magnetic resonance imaging using liver-specific contrast for focal lesions in clinical practice.World journal of hepatology · 2022
   Article
7. A Scoping Review of the Classification, Diagnosis, and Management of Hepatic Adenomas.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2022
   Article
8. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma.La Radiologia medica · 2021
   Article
9. Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors.International journal of molecular sciences · 2021
   Review
10. MRI characterization of focal liver lesions in non-cirrhotic patients: assessment of added value of gadoxetic acid-enhanced hepatobiliary phase imaging.Insights into imaging · 2020
    Article
11. An elderly man with progressive focal nodular hyperplasia.Clinical journal of gastroenterology · 2020
    Article
12. Multi-parameter ultrasound based on the logistic regression model in the differential diagnosis of hepatocellular adenoma and focal nodular hyperplasia.World journal of gastrointestinal oncology · 2019
    Article
13. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.Journal of ultrasound · 2019
    Article
14. Hepatocellular adenoma: An unsolved diagnostic enigma.World journal of gastroenterology · 2019
    Review
15. New MRI features improve subtype classification of hepatocellular adenoma.European radiology · 2019
    Article
16. Current Approaches in the Management of Hepatic Adenomas.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2019
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors at 3 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as